Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E21.48 EPS (ttm)6.03 Insider Own0.07% Shs Outstand2.65B Perf Week2.04%
Market Cap343.60B Forward P/E14.20 EPS next Y9.12 Insider Trans0.17% Shs Float2.64B Perf Month-0.77%
Income16.33B PEG3.32 EPS next Q2.00 Inst Own70.00% Short Float0.59% Perf Quarter-7.10%
Sales81.33B P/S4.23 EPS this Y7.60% Inst Trans0.21% Short Ratio2.09 Perf Half Y-5.56%
Book/sh22.92 P/B5.65 EPS next Y6.04% ROA10.60% Target Price149.35 Perf Year-7.40%
Cash/sh5.76 P/C22.49 EPS next 5Y6.47% ROE26.80% 52W Range121.00 - 148.99 Perf YTD0.38%
Dividend3.80 P/FCF39.80 EPS past 5Y3.10% ROI17.00% 52W High-13.05% Beta0.69
Dividend %2.93% Quick Ratio1.00 Sales past 5Y2.70% Gross Margin66.80% 52W Low7.06% ATR1.96
Employees135100 Current Ratio1.30 Sales Q/Q-1.30% Oper. Margin23.40% RSI (14)48.41 Volatility1.58% 1.44%
OptionableYes Debt/Eq0.48 EPS Q/Q43.40% Profit Margin20.10% Rel Volume0.66 Prev Close130.78
ShortableYes LT Debt/Eq0.46 EarningsOct 15 BMO Payout59.60% Avg Volume7.41M Price129.54
Recom2.30 SMA200.00% SMA50-1.53% SMA200-4.23% Volume4,859,456 Change-0.95%
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Sep-16-19 02:03PM  Purdue Pharma Files For Bankruptcy: What You Need To Know Benzinga
11:30AM  S&P 500 buybacks decline significantly in Q2 2019; expenditures still remain higher than the pre-2018 levels PR Newswire
10:43AM  AstraZeneca's Farxiga Gets Fast Track Tag for Heart Failure Zacks
08:48AM  Amgen's Kyprolis Combo Improves PFS in Multiple Myeloma Study Zacks
06:25AM  CMR Surgical hits £1bn valuation as it rolls out robots for surgery Financial Times
12:30AM  UPDATE 1-OxyContin maker Purdue Pharma files for bankruptcy protection Reuters
Sep-15-19 11:22PM  OxyContin maker Purdue Pharma files for bankruptcy protection Reuters
Sep-13-19 09:46AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From GSK, PFE & Others Zacks
Sep-12-19 05:20PM  6 Stocks With Low Price-Sales Ratios GuruFocus.com
03:43PM  Alabama hospitals file suit against opioid manufacturers and distributors American City Business Journals
03:23PM  Rep. McHenry says Trump is publicly saying what everybody privately grumbles about Yahoo Finance Video
09:41AM  J&J's Ponesimod Superior to Aubagio in Relapsing MS Patients Zacks
09:28AM  9 Best Dividend Stocks to Buy for Every Investor InvestorPlace
Sep-11-19 05:45PM  Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know Zacks
12:13PM  Mallinckrodt to Divest Contract Manufacturing Unit, Stock Up Zacks
09:46AM  Lexicon (LXRX) Settles With Sanofi for $260M, Shares Rally Zacks
Sep-10-19 03:55PM  Dow flat despite gains for Dow Inc., Boeing stocks MarketWatch
11:46AM  Theravance Announces Positive Early Data on JAK Inhibitor Zacks
10:55AM  10 Healthcare Stocks to Buy Despite the Headlines InvestorPlace
Sep-09-19 05:28PM  Mallinckrodt (MNK) to Resolve Opioid Cases with Ohio Counties Zacks
11:33AM  The Zacks Analyst Blog Highlights: Allergan, Merck, Roche, J&J and Bristol-Myers Zacks
09:44AM  An Intrinsic Calculation For Johnson & Johnson (NYSE:JNJ) Suggests It's 43% Undervalued Simply Wall St.
Sep-08-19 07:28PM  Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August Motley Fool
Sep-07-19 12:16PM  The 11 Biggest Dividend Stocks on the Market Motley Fool
Sep-06-19 11:36AM  Pharma Stock Roundup: AGN's Opioid Settlement, Line Extension Nod in EU for MRK, JNJ Drugs Zacks
08:50AM  Mallinckrodts suffers record plunge after report bankruptcy is being considered MarketWatch
08:08AM  Mallinckrodt Mulls Bankruptcy Ahead of Major Opioid Litigation Zacks
Sep-05-19 06:28PM  How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks? Motley Fool
10:35AM  Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease Zacks
10:18AM  J&J's Stelara Gets Approval in EU for Ulcerative Colitis Zacks
10:02AM  [video]Johnson & Johnson Is Especially Attractive in Today's Low-Rate Environment TheStreet.com
08:00AM  Johnson & Johnson Is A Massive Pharma Stock But Should You Buy It? Investor's Business Daily
07:55AM  4 Defensive Dividend Stocks for Steady Returns TipRanks
03:10AM  [video]Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy TheStreet.com
12:00AM  J&J: The next target of anger over Americas opioid crisis? Financial Times
Sep-04-19 05:45PM  Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know Zacks
08:20AM  Forget Coca-Cola: Here Are 2 Better Dividend Stocks Motley Fool
Sep-03-19 04:15PM  What the Johnson & Johnson Opioid Ruling Means for the Cannabis Industry Motley Fool
03:50PM  UPDATE 1-U.S. judge orders big drug companies to face opioid trial Reuters
09:21AM  The Zacks Analyst Blog Highlights: J&J, Eli Lilly, Bristol-Myers, Roche and AbbVie Zacks
08:52AM  Bayer hires former J&J executive for more pharma deals Reuters
Sep-02-19 09:41AM  Allergan Settles Ahead of Multi-District Opioid Litigation Zacks
09:15AM  Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now Zacks
07:51AM  Here's Why Glaxo (GSK) Steadily Stays Ahead of Its Industry Zacks
06:06AM  3 Surefire Dividend Stocks to Pass On to Your Kids or Grandkids Motley Fool
Aug-31-19 03:37PM  Bulls And Bears Of The Week: Altria, Apple, Netflix, Slack And More Benzinga
Aug-30-19 04:18PM  Dow Jones Rallies On China Trade Hopes; J&J Opioid Ruling, Best Buy, Burlington Stores, Ulta Beauty Earnings: Weekly Review Investor's Business Daily
04:09PM  How the Johnson & Johnson Ruling Could Affect the Opioid Cases Barrons.com
01:43PM  Its Time to Short Johnson & Johnson Stock InvestorPlace
11:37AM  3 Large-Cap Stocks to Sell in September InvestorPlace
11:02AM  Purdue eyeing $12 billion settlement for 2,000 lawsuits Yahoo Finance Video
10:21AM  AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails Zacks
10:11AM  Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs Zacks
08:00AM  Will Opioid Litigation Take its Toll on Pharma Companies? Zacks
01:53AM  Litigation alone cannot heal the opioid epidemic Financial Times
Aug-29-19 09:36PM  A selection of the FTs biggest stories and best reads every Friday Financial Times
05:18PM  Citi Turns Bullish On Jabil, Says Customer Risk Concentration 'Played Out' Benzinga
04:24PM  Johnson & Johnson to Participate in the 2019 Morgan Stanley 17th Annual Global Healthcare Conference PR Newswire
04:21PM  Why This Newly Profitable Biotech Stock Is Flirting With A Breakout Investor's Business Daily
03:38PM  Papa John's Is Ready for Its Turnaround Motley Fool
11:04AM  Time Is Running Out for Johnson & Johnson Bulls Investopedia
10:18AM  Geron (GERN) Stock Rises 40% in 2019 So Far: Here's Why Zacks
07:37AM  Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar? Zacks
Aug-28-19 04:55PM  US Stocks Edge Higher Wednesday GuruFocus.com
04:29PM  What Purdue's Rumored Deal Means For Other Opioid-Tied Pharmas Investor's Business Daily
04:13PM  J&J (JNJ) Loses Landmark Opioid Case: What's Next for Pharmaceuticals? Zacks
03:34PM  Johnson and Johnson Opioid Lawsuit and More Doom and Gloom Zacks
02:40PM  Trump Wants the VA to Get as Much of This Drug as It Can Motley Fool
11:27AM  Johnson & Johnson International Fin Svc Co -- Moody's affirms J&J at Aaa; revises outlook to negative Moody's
09:45AM  Microsoft, Visa share losses contribute to Dow's 65-point fall MarketWatch
09:26AM  Analysts view Johnson & Johnsons $572 million fine as a win MarketWatch
08:02AM  Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates Benzinga
07:09AM  We cannot win the war on drugs by obsessing over supply Financial Times
05:30AM  Podcast: An August Climb for Treasuries Barrons.com
12:00AM  Opioids Threaten to Mess Up Europe, Too Bloomberg
Aug-27-19 06:37PM  Strategic Value Investing: Free Cash Flow Models GuruFocus.com
05:45PM  Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know Zacks
04:27PM  The J&J Opioid Lawsuit Could Let the Real Culprits Off the Hook Bloomberg
04:17PM  Stocks close lower as trade-fight concerns linger, yield-curve inversion deepens MarketWatch
04:14PM  Why The Opioid Verdict Is Actually A 'Devastating Body Blow' For J&J Investor's Business Daily
04:13PM  Dow Jones Today: Not Much Activity, But Thats OK InvestorPlace
04:12PM  5 Top Stock Trades for Wednesday: CMG, SBUX, JNJ InvestorPlace
04:04PM  US Stock Market Overview – Stocks Close Mixed, US Yields Continue to Invert FX Empire
04:03PM  Stock Market in the Red on Tuesday GuruFocus.com
03:34PM  The S&P 500's Wild August, HubSpot Stock & More - Free Lunch Zacks
03:24PM  Why The Opioid Verdict Is Actually A 'Devastating Body Blow' For J&J Investor's Business Daily
03:17PM  UPDATE 5-Purdue Pharma in discussion on $10 bln-$12 bln offer to settle opioid lawsuits -sources Reuters
03:01PM  Dow Jones Close To Testing Long-Term Support As Stocks Reverse Investor's Business Daily
02:17PM  Why Johnson & Johnson's Stock Rose After Ordered to Pay $572M Fine In Opioid Outbreak Verdict SAY
01:43PM  US STOCKS-Wall Street slips as financials fall, trade hopes flicker Reuters
01:03PM  Why One Johnson & Johnson Analyst Sees Oklahoma Opioid Ruling As Near-Term Sentiment Positive Benzinga
12:24PM  The J&J Opioid Verdict Is Just How the U.S. Does Regulation Bloomberg
12:23PM  Johnson & Johnson Ruling Is Seen as a Relief, but 1 Analyst Deems It Very Bearish Barrons.com
12:21PM  US STOCKS-Wall Street treads water as financials fall, trade hopes flicker Reuters
12:03PM  [video]Purdue Pharma Reportedly Offers $10 Billion to $12 Billion for Opioid Settlements TheStreet.com
11:42AM  A Look At Benzinga Pro's Most-Searched Tickers For August 27, 2019 Benzinga
11:36AM  Lilly's (LLY) Taltz Gets FDA Nod for Ankylosing Spondylitis Zacks
11:32AM  AstraZeneca's Farxiga Gets Fast Track Tag for Renal Outcome Zacks
11:14AM  J&J to Pay $572M in Opioid Case; Plus Case-Shiller Home Price Read Zacks
11:01AM  J&J Up Despite $572M Fine in Oklahoma Opioid Abuse Case Zacks
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM